F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy
about
Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US.18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference RegionsPrognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy.Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy - the influence of the choice of the reference region and conversion function.Imaging the Tumor Microenvironment.(18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer.FMISO as a Biomarker for Clinical Radiation Oncology.Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer.Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical ImagingPrognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.Multimodality Imaging in Tumor Angiogenesis: Present Status and PerspectivesImpact of tissue transport on PET hypoxia quantification in pancreatic tumours.Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription.Imaging the Tumor Microenvironment.Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model.Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine.
P2860
Q30395717-EB52FDCC-FD49-4CA2-A912-8FCA5B9B2089Q30660095-53FAFC61-4281-4F72-8CE2-CD26C1DF47A3Q36467475-23330D20-6963-4245-B344-988798E5461FQ37193204-E5818AD7-2351-46BF-858E-58F0F6AC6736Q37559704-57AF6B2B-1EEF-4AC5-9FF6-B151EB524762Q38401218-6DE3C32F-9AF6-43A8-9FD4-CCD80392CC6CQ38518224-E94AA827-AA52-4046-92EF-1F3D7DF0E7BDQ38836045-29C64B33-F342-4E6D-BE48-7DE07103A629Q38869449-F7A5C27F-BEE8-41CC-A702-C66AF1F06ADCQ38942626-CCC33456-6656-41BC-9DFD-9EA05E4A40D9Q38968830-2AFF114E-9030-4498-842C-6FFB8A4803B4Q39135714-19696E2B-7718-4E39-A73D-96551449746CQ40217094-AC76AAE2-7326-4BD8-BB57-0225F556D12BQ41661199-4E8F8C74-8209-485D-899E-991830CB9D4AQ47115519-D2709B40-CE37-4A86-9D8E-86E140B83E89Q47591784-5CFE1411-1FB8-4D9B-9446-B76D453945C6Q49592815-AEF3F435-0D33-4437-8FF3-A32F3E605807Q51079367-19DAB58A-553B-4F84-90CA-4200F23B1F1BQ51514274-85ABAFF5-362E-4BF1-AEF5-899AAB4D51A2Q51559766-3690B207-158B-4AC8-BD95-BCB44D3A59A4Q53109990-D7457D32-F22F-4398-8C43-0918F29EBD38
P2860
F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
F-18 fluoromisonidazole for im ...... or personalized cancer therapy
@ast
F-18 fluoromisonidazole for im ...... or personalized cancer therapy
@en
type
label
F-18 fluoromisonidazole for im ...... or personalized cancer therapy
@ast
F-18 fluoromisonidazole for im ...... or personalized cancer therapy
@en
prefLabel
F-18 fluoromisonidazole for im ...... or personalized cancer therapy
@ast
F-18 fluoromisonidazole for im ...... or personalized cancer therapy
@en
P2860
P1476
F-18 fluoromisonidazole for im ...... or personalized cancer therapy
@en
P2093
Joseph G Rajendran
Kenneth A Krohn
P2860
P304
P356
10.1053/J.SEMNUCLMED.2014.10.006
P577
2015-03-01T00:00:00Z